Aurobindo Pharma stock drops 4.5% after Q4 PAT misses estimates

The company's PAT declined by 0.7% yoy to Rs 528.8cr in Q4FY18.

from India Infoline News Service https://ift.tt/2L45Ufu

Comments

Popular posts from this blog

What are the key measures of market volatility?

https://ift.tt/2IVHF6y